StockMarketWire.com - Scancell Holdings, which develops immunotherapies for the treatment of cancer, said it would present at separate conferences in London and Shanghai.

Chief executive Cliff Holloway would present an overview of the company at the LSX conference in London on 13 November.

In addition, current director and previous CEO Richard Goodfellow would present at the BioCentury-BayHelix China Healthcare Summit in Shanghai, held on 13-14 November.

At 9:49am: [LON:SCLP] Scancell Holdings PLC share price was +0.15p at 8.9p



Story provided by StockMarketWire.com